Down-regulation of HaIr1 during induced differentiation of embryonal carcinoma P19 cells

被引:1
|
作者
Hosseininia, Zahra [1 ]
Soltanian, Sara [2 ]
Mahdavi-Shahri, Naser [3 ]
Dehghani, Hesam [1 ,4 ]
机构
[1] Ferdowsi Univ Mashhad, Fac Vet Med, Div Biotechnol, Mashhad, Razavi Khorasan, Iran
[2] Shahid Bahonar Univ Kerman, Fac Sci, Dept Biol, Kerman, Iran
[3] Ferdowsi Univ Mashhad, Fac Sci, Dept Biol, Mashhad, Razavi Khorasan, Iran
[4] Ferdowsi Univ Mashhad, Res Inst Biotechnol, Stem Cells & Regenerat Med Res Grp, Mashhad, Razavi Khorasan, Iran
关键词
Differentiation; Halr1; lincRNA; Pluripotency; P19; cell; Retinoic acid; LONG NONCODING RNA; TRANSCRIPTION FACTOR; RETINOIC ACID; PLURIPOTENCY; EXPRESSION; CHROMATIN; RECRUITMENT; NANOG; OCT4; MAINTENANCE;
D O I
10.32604/biocell.2019.06468
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Maintenance of pluripotency depends to diverse regulatory factors. Studies in embryonic stem cells (ESCs) have indicated that large intergenic non-coding RNAs (lincRNAs) are involved in the regulatory network of pluripotency. However, the presence and function of pluripotency-associated lincRNAs in cancer cells with pluripotency features are unknown. In this study, we used embryonal carcinoma (EC) P19 cell lines to investigate the expression level of Halr1 in pluripotency and retinoic acid (RA)-induced differentiated states. Down-regulation of pluripotency associated factors such as OCT4, NANOG, SSEA1 and alkaline phosphatase at transcript and protein levels were used to confirm the differentiated status of P19 cells. Quantitative measurement of Halr1 transcript levels revealed a 79% decrease during RA-induced differentiation of P19 cells. These results indicate that upon exiting the pluripotency state the expression level of Halr1 similar to core pluripotency factors is remarkably reduced.
引用
收藏
页码:145 / 154
页数:10
相关论文
共 50 条
  • [31] TRANSIENT EXPRESSION OF THE PROTO-ONCOGENE INT-1 DURING DIFFERENTIATION OF P19 EMBRYONAL CARCINOMA-CELLS
    SCHUURING, E
    VANDEEMTER, L
    ROELINK, H
    NUSSE, R
    MOLECULAR AND CELLULAR BIOLOGY, 1989, 9 (03) : 1357 - 1361
  • [32] DIFFERENTIAL EXPRESSION OF JUN AND FOS GENES DURING DIFFERENTIATION OF MOUSE P19 EMBRYONAL CARCINOMA-CELLS
    DEGROOT, RP
    SCHOORLEMMER, J
    VANGENESEN, ST
    KRUIJER, W
    NUCLEIC ACIDS RESEARCH, 1990, 18 (11) : 3195 - 3202
  • [33] Changes in pre-mRNA splicing factors during neural differentiation in P19 embryonal carcinoma cells
    Shinozaki, A
    Arahata, K
    Tsukahara, T
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 1999, 31 (11): : 1279 - 1287
  • [34] Early expression of the BM88 antigen during neuronal differentiation of P19 embryonal carcinoma cells
    Boutou, E
    Hurel, C
    Matsas, R
    INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE, 2000, 18 (2-3) : 321 - 328
  • [35] Valproic Acid-Induced Alterations in CBP/p300 Regulation in P19 Embryonal Carcinoma Cells
    Lamparter, C. L.
    Winn, L. M.
    BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY, 2014, 100 (05) : 388 - 388
  • [36] Regulation of sulfoglucuronyl carbohydrate (HNK-1) synthesis in retinoic acid-induced P19 embryonal carcinoma cells
    Henion, TR
    McCaffery, P
    Chou, DKH
    Jungalwala, FB
    GLYCOBIOLOGY, 2000, 10 (10) : 1100 - 1101
  • [37] Chemotherapy-associated toxicity on p19 embryonal carcinoma cells: role of differentiation state
    Mesquita, K. A.
    Vega-Naredo, I.
    Oliveira, P. J.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2013, 43 : 97 - 98
  • [38] Overexpression of APRIN inhibits differentiation and proliferation and promotes apoptosis in P19 embryonal carcinoma cells
    Zhou, Xiang
    Kong, Xiangqing
    Xu, Weiting
    Chen, Jianchang
    MOLECULAR BIOLOGY REPORTS, 2013, 40 (01) : 491 - 495
  • [39] THE VIRAL AND CELLULAR REL ONCOPROTEINS INDUCE THE DIFFERENTIATION OF P19 EMBRYONAL CARCINOMA-CELLS
    INUZUKA, M
    ISHIKAWA, H
    KUMAR, S
    GELINAS, C
    ITO, Y
    ONCOGENE, 1994, 9 (01) : 133 - 140
  • [40] Relevance of differentiation phenotype on DNA damage detection and repair in P19 embryonal carcinoma cells
    Erickson, J. R.
    Vega-Naredo, I.
    Mesquita, K. A.
    Perkins, E. L.
    Oliveira, P. J.
    Holy, J.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2012, 42 : 79 - 80